Skip to main content
. 2022 Mar 8;12:4036. doi: 10.1038/s41598-022-08019-0

Table 3.

Spectrum of ATM gene variants in the North Indian patients with A-T.

Case no Zygosity Variants Affected ATM protein domain Clinical significance*
Exon cDNA nucleotide change Protein change Type
3 CH 24 c.3546_3547delGA p.Asn1183TrpfsTer16 Frameshift HEAT Pathogenic
50 c.7456C>T p.Arg2486Ter Nonsense FAT Pathogenic
4 H 45 c.6547G>T p.Glu2183Ter Nonsense FAT Pathogenic
5# H 45 c.6547 G>T p.Glu2183Ter Nonsense FAT Pathogenic
6# H 45 c.6547 G>T p.Glu2183Ter Nonsense FAT Pathogenic
7 CH 10 c.1339C>T p.Arg447Ter Nonsense HEAT Pathogenic
58 c.8473C>T p.Gln2825Ter Nonsense PI3K Pathogenic
8 H Intron 42–43 c.6198+1G>T Splice site variant Donor splicing variant FAT Likely pathogenic
9 H 2 c.67 C>T p. Arg23Ter Nonsense N-terminal-TAN Pathogenic
10 H 46 c.6658 C>T p.Gln2220Ter Nonsense FAT Pathogenic
11 CH 10 c.1339C>T p.Arg447Ter Nonsense HEAT Pathogenic
58 c.8473C>T p.Gln2825Ter Nonsense PI3K Pathogenic
12 H 43 c.6219_6229delCTGCCATATTC p.Cys2074PhefsTer10 Frameshift FAT Pathogenic
13 H 2 c.67C>T p.Arg23Ter Nonsense N-terminal-TAN Pathogenic
14 H 42 c.6100C>T p.Arg2034Ter Nonsense FAT Pathogenic
15 CH 2 c.67C>T p.Arg23Ter Nonsense N-terminal-TAN Pathogenic
Intron 20–21 c.3077+1G>T Splice site variant Donor splicing variant HEAT Likely pathogenic
16 CH 37 c.5631_5635delCTCGCinsA p.Phe1877LeufsTer39 Frameshift HEAT Pathogenic
49 c.7307G>A p.Arg2436Lys Missense variant (affecting donor splice site) FAT VUS
17 H 52 c.7788G>C p.Glu2596Asp Missense variant (affecting donor splice site) FAT-PI3K VUS
18 CH 37 c.5631_5635delCTCGCinsA p.Phe1877LeufsTer39 Frameshift HEAT Pathogenic
49 c.7307G>A p.Arg2436Lys Missense variant (affecting donor splice site) FAT VUS
26 H 37 c.5631_5635delCTCGCinsA p.Phe1877LeufsTer39 Frameshift HEAT Pathogenic

#Siblings; CH compound heterozygous, H homozygous, PI3K phosphatidylinositol 3-kinase, FAT FAT domain, TAN telomere-length maintenance and DNA damage repair domain, VUS variant of uncertain significance. *As per ACMG guidelines.